Xanthorrhizol
CAS No. 30199-26-9
Xanthorrhizol ( —— )
产品货号. M26509 CAS No. 30199-26-9
Xanthorrhizol is a natural product isolated from Curcuma xanthorrhiza Roxb. Xanthorrhizol is a potential antibacterial agent.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥5816 | 有现货 |
|
10MG | ¥8076 | 有现货 |
|
25MG | ¥11988 | 有现货 |
|
50MG | ¥16119 | 有现货 |
|
100MG | ¥21789 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Xanthorrhizol
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Xanthorrhizol is a natural product isolated from Curcuma xanthorrhiza Roxb. Xanthorrhizol is a potential antibacterial agent.
-
产品描述Xanthorrhizol is a natural product isolated from Curcuma xanthorrhiza Roxb. Xanthorrhizol is a potential antibacterial agent.(In Vivo):Inhibition of ear edema caused by topical use of TPA by pretreatment with xanthine in a dose-related manner (P <0.005).In mice, Topical application of Xanthorrhizol alone does not induce ear edema . All the mice treated with 7.5 nM TPA for 19 weeks after initiation by DMBA developed an average of 15.5±2.3 skin tumors per mouse (tumor multiplicity). Pre-treatment with 2 and 6 μM Xanthorrhizol reduces tumor multiplicity to 6.9±1.1 (P<0.005) and 4.0±1.1 (P<0.005), respectively, at 19 weeks.
-
同义词——
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体Androgen Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number30199-26-9
-
分子量218.3
-
分子式C15H22O
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC[C@H](CCC=C(C)C)c1ccc(C)c(O)c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Dart DA, et al. Novel Trifluoromethylated Enobosarm Analogues with Potent Antiandrogenic Activity?In Vitro?and Tissue Selectivity?In Vivo.Mol Cancer Ther.?2018 Sep;17(9):1846-1858.
产品手册
关联产品
-
6-Chloro-7-deazapuri...
6-Chloro-7-deazapurine-β-D-riboside shows antifungal activity.
-
Ceratotoxin B
Ceratotoxins B is antibacterial peptide produced by the sexually mature females of Ceratitis capitata.
-
Loganetin
Loganetin, a non-toxic natural product, shows antibacterial activity against multidrug-resistant Gram-negative infections.